Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Nov 7, 2019; 25(41): 6273-6288
Published online Nov 7, 2019. doi: 10.3748/wjg.v25.i41.6273
Table 2 Clinical characteristics of patients and controls
CharacteristicCD (n = 90)UC (n = 90)HCs (n = 80)PCs (n = 35)
Male/female48/4238/5246/3419/16
Mean age (yr)39.94 ± 11.8041.69 ± 12.4037.64 ± 9.3042.40 ± 10.20
Range (yr)17-6720-7320-7218-70
Tobacco smoking (n)
Never60675020
Past or current use30233015
Disease duration (yr)5.1 ± 3.15.1 ± 3.4
Disease location: CD, n (%)
L137 (41.1)
L220 (22.2)
L333 (36.7)
Disease activity: CDAI, n (%)
Remission16 (17.8)
Mild19 (21.1)
Moderate40 (44.4)
Severe15 (16.7)
Disease behavior:CD, n (%)
B139 (43.3)
B233 (36.7)
B318 (20.0)
Disease location: UC, n (%)
E136 (40.0)
E229 (32.2)
E325 (27.8)
Disease severity, n (%)
Remission14 (15.6)
Mild30 (33.3)
Moderate31 (34.4)
Severe15 (16.7)
Medications, n (%)
5-ASA80 (88.9)87 (96.7)
Corticosteroids50 (11.7)41 (45.5)
Immunosuppressants28 (31.1)14 (15.6)
Anti-TNF-α13 (14.4)4 (4.4)
Surgery4 (4.4)1 (1.1)